-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
Akero Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2020 to 2024.
- Akero Therapeutics, Inc. Operating Lease, Payments for the quarter ending December 31, 2024 was $84K, a 2.44% increase year-over-year.
- Akero Therapeutics, Inc. Operating Lease, Payments for the twelve months ending December 31, 2024 was $331K, a 3.12% increase year-over-year.
- Akero Therapeutics, Inc. annual Operating Lease, Payments for 2024 was $331K, a 3.12% increase from 2023.
- Akero Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $321K, a 2.89% increase from 2022.
- Akero Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $312K, a 2.97% increase from 2021.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)